The study of antithrombotic efficacy, safety and tolerability of aspirin generic in patients with coronary heart disease
The aim of the study was to investigate the antithrombotic efficiency, safety and tolerance of Lospirintm in patients with coronary artery disease. The study involved 50 patients (32 men and 18 women) aged 40-65 years with disease duration from 3 to 27 years, receiving daily one tablet of Lospirintm...
Saved in:
| Main Authors: | Khomaziuk T.A., Novozhenina L.I., Levykh А.Е., Kryzhanovska S.I., Hrytsenko V.I. |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dnipro State Medical University
2013-10-01
|
| Series: | Medičnì Perspektivi |
| Subjects: | |
| Online Access: | http://medpers.dsma.dp.ua/issues/2013/N3/37-43.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01) -
Extended dual antithrombotic therapy in patients with chronic coronary syndrome — which agent should be added to aspirin?
by: Jacek Kubica, et al.
Published: (2025-06-01) -
Up-to-date potential of antithrombotic therapy in patients with coronary artery disease and diabetes
by: O. D. Ostroumova, et al.
Published: (2020-09-01) -
Antithrombotic therapy in clinical practice
by: J.A. Ker, et al.
Published: (2003-03-01) -
Management of Antithrombotic in Endoscopic Procedures
by: Dwi Suseno, et al.
Published: (2018-03-01)